Source: Revive Therapeutics Ltd.
  • Revive Therapeutics (RVV) and PharmaTher (PHRM) signed a research collaboration agreement to evaluate the delivery of MDMA using microneedle patch delivery technology
  • PharmaTher’s novel MN-Patch can penetrate the outer layer of the skin, enable flexible drug load capacity and combinations, and control-release delivery
  • The team completed a non-clinical research study evaluating its delivery. Results will be available in early Q2 2023, intended to support a potential human clinical study
  • Revive Therapeutics Ltd. (RVV) was down 3.57 per cent, trading at C$0.13 per share, and PharmaTher (PHRM) was down 8.57 per cent, trading at C$0.16 per share

Revive Therapeutics (RVV), and PharmaTher (PHRM) have signed a research collaboration agreement.

Under the agreement, the companies will evaluate the delivery of MDMA using microneedle patch delivery technology.

PharmaTher’s novel MN-Patch can penetrate the outer layer of the skin, enable flexible drug load capacity and combinations, and control-release delivery. The team completed a non-clinical research study evaluating its delivery. Results will be available in early Q2 2023 to support a potential human clinical study.

Revive’s CEO, Michael Frank, commented that the MDMA microneedle patch will complement his company’s psilocybin programs for mental health and abuse disorders.

“We look forward to advancing the MDMA patch program that could fill the gaps that we believe could offer an advantage to oral MDMA treatments.”

Revive is a life sciences company focused on the research and development of therapeutics for infectious diseases and rare disorders.

PharmaTher Holdings Ltd. (PHRM) is a psychedelics biotech company focused on the research, development, and commercialization of psychedelics, such as ketamine, to treat mental health, neurological and pain disorders. 

Revive Therapeutics Ltd. (RVV) was down 3.57 per cent, trading at C$0.13 per share.

PharmaTher (PHRM) was down 8.57 per cent, trading at C$0.16 per share.


More From The Market Online

Foraco International exits Russia

Foraco International (TSX:FAR) announced the completion of the sale of its shareholding in its subsidiary, EDC Russia.

Undervalued copper stock reports more stellar results

Pampa Metals (CSE:PM), an undervalued copper stock, reveals outstanding final assays from its Piuquenes project in Argentina.

Sona Nanotech files patent application for photothermal light device

Sona Nanotech (CSE:SONA) submits a patent application to the U.S. Patent and Trademark Office for its proprietary photothermal light device.
Canada Nickel Company logo

Canada Nickel makes new discovery

Canada Nickel (TSXV:CNC) reports a mineral discovery at its Newmarket property and the best drill result to date from its Reid property.